Diabète

Evaluation of the Adherence to Continuous Glucose Monitoring in the Management of Type 1 Diabetes Patients on Sensor-Augmented Pump Therapy: The SENLOCOR Study.

Continuous glucose monitoring (CGM) and sensor-augmented pump (SAP) therapy improve glucose control provided good adherence. In France, not only diabetologists, nurses, and dieticians but also nurses employed by homecare providers (HCPNs) are together involved in the initiation and/or follow-up of continuous subcutaneous insulin injection (CSII) and SAP training. The SENLOCOR Study is an observational study designed to assess SAP adherence over 6 months (primary objective). Secondary objectives included the impact of SAP on metabolic control and patients’ satisfaction.
Mar 2016 · Diabetes Technol Ther
Picard S, Hanaire H, Baillot-Rudoni S, Gilbert-Bonnemaison E, Didier Not, Reznik Y, Guerci B

Vous souhaitez échanger
avec nos équipes

Contactez-nous

D’autres articles qui pourraient
vous intéresser

Closed-loop insulin delivery in adults with type 1 diabetes in real-life conditions: a 12-week multicentre, open-label randomised controlled crossover trial
Diabète

Closed-loop insulin delivery in adults with type 1 diabetes in real-life conditions: a 12-week multicentre, open-label randomised controlled crossover trial

Sucrose octasulfate dressing versus control dressing in patients with neuroischaemic diabetic foot ulcers (Explorer) – an international, multicentre, double-blind, randomised, controlled trial
Diabète

Sucrose octasulfate dressing versus control dressing in patients with neuroischaemic diabetic foot ulcers (Explorer) – an international, multicentre, double-blind, randomised, controlled trial

Projet Diabeloop de développement d’un pancréas artificiel chez des diabétiques de type 1 – intérêt d’un deuxième capteur de glycémie dans un système de régulation automatique de la glycémie
Diabète

Projet Diabeloop de développement d’un pancréas artificiel chez des diabétiques de type 1 – intérêt d’un deuxième capteur de glycémie dans un système de régulation automatique de la glycémie